Table 2.
Concentration of adipocytokines in the serum of patients depending on the presence of MetS, Me (Q1; Q3).
| Indicators | Patients with MetS (n = 46) |
Patients without MetS (n = 64) |
p-Value |
|---|---|---|---|
| Leptin, pg/mL | 13.51 (7.44; 27.77) | 6.66 (2.15; 11.38) | <0.001 * |
| Adiponectin, μg/mL | 6.39 (4.71; 8.97) | 11.33 (7.18; 14.65) | 0.002 * |
| Leptin–adiponectin ratio | 3.31 (0.76; 5.00) | 0.77 (0.37; 2.00) | 0.002 * |
| TNF-α, pg/mL | 20.75 (15.38; 26.15) | 18.39 (12.22; 24.70) | 0.169 |
| IL-6, pg/mL | 5.16 (4.00; 8.25) | 6.03 (4.60; 7.92) | 0.302 |
Me (Q1;Q3), median (lower quartile; upper quartile); TNF-α, tumor necrosis factor-alpha; IL-6, interleukin 6. * p < 0.05, statistically significant difference. Comparisons between groups were performed using the Mann–Whitney U test.